Summary & Overview
HCPCS J1643: Heparin Sodium (Pfizer), per 1000 Units
HCPCS Level II code J1643 denotes the supply of heparin sodium (Pfizer), billed per 1000 units, and specifies that this product is not therapeutically equivalent to J1644. This medication-level code matters nationally because heparin remains a core anticoagulant in acute care, procedural settings, and hospital workflows; accurate coding ensures precise drug inventory tracking and appropriate payer adjudication. Common sites of service include inpatient and outpatient hospital settings, ambulatory clinics, emergency departments, and other facilities providing parenteral anticoagulation.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise discussion of the clinical context for heparin sodium use, coding distinctions relative to therapeutically non-equivalent products, and what to expect in payer coverage patterns. The publication outlines coding benchmarks, typical billing and service-line placement, and policy considerations relevant to medication-specific HCPCS reporting. Where source input is absent, the report notes that specific taxonomies, ICD-10 pairings, and related codes are not provided in the input. The aim is to equip billing professionals and policy analysts with a clear, national-level reference for HCPCS Level II code J1643.
Billing Code Overview
HCPCS Level II code J1643 represents the injection of heparin sodium (Pfizer), not therapeutically equivalent to J1644, billed per 1000 units. This code applies to the medication product and dosage unit for heparin sodium supplied for parenteral administration.
Service Type: Injectable anticoagulant medication administration / drug supply
Typical Site of Service: Hospital inpatient or outpatient, ambulatory clinic, emergency department, or other settings where parenteral anticoagulant therapy is administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a hospitalized adult receiving anticoagulation for prevention of venous thromboembolism or for patency of an indwelling catheter. The clinician orders J1643 (heparin sodium, per 1,000 units) when medication selection requires a specific manufacturer product (Pfizer) that is not therapeutically equivalent to J1644. A common scenario: an internal medicine physician or hospitalist prescribes subcutaneous heparin for deep vein thrombosis prophylaxis postoperatively, or a critical care team administers intravenous heparin infusion with bolus doses during hemodialysis or for maintaining central venous catheter patency. Nursing prepares and documents the administered units and links the HCPCS code to the medication administration record for billing. Billing staff append clinically appropriate modifiers to indicate unusual circumstances (e.g., discontinued service, reduced services, product wastage) and submit claims to payors including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare according to facility and payer-specific guidelines.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug discarded/unused | When part of the drug vial is discarded and wastage must be reported for payable recovery |